Close Menu

A functional genomic screen has revealed a new drug combination that boosts the efficacy of KRAS inhibitors for aggressive lung cancer. As reported in Science Translational Medicine, a team led by scientists from the Francis Crick Institute found that a combination of MEK enzyme and IGF1R receptor inhibitors, which shows promise for KRAS-mutant lung cancers in preclinical studies, could be further enhanced by the addition of an mTOR inhibitor.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.